OmegaacademixBackground
Pathological scars — hypertrophic scars and keloids — are common after surgery, trauma, and burns, affecting up to 16% of burn patients and around 3.5% of Black African populations for keloids specifically. Silicone-based products have been used in scar management since the 1980s and are widely regarded as first-line, gold-standard therapy. But the evidence specifically for topical silicone gel (as opposed to silicone gel sheeting) has been genuinely inconsistent: a Cochrane review found silicone gel sheeting effective, while a separate meta-analysis by Hsu et al. found that topical gel did not outperform placebo. Wang and colleagues conducted this new systematic review and meta-analysis, published in the International Wound Journal, specifically to resolve this question and to test whether the dressing format (gel vs. sheet) actually matters for efficacy.
Review Snapshot
| Design | Systematic review and meta-analysis of RCTs | Databases | PubMed, Web of Science, Embase |
|---|---|---|---|
| Studies included | 6 RCTs (from 487 screened) | Population | 375 patients total |
| Outcome tool | Vancouver Scar Scale (VSS) | Follow-up range | 12 weeks to 12 months |
| Comparators | Placebo/no treatment; silicone gel sheet; non-silicone topicals | Analysis software | Review Manager 5.3 (Cochrane) |
Key Findings
- At 3 months after surgery, topical silicone gel showed no significant advantage over placebo or no treatment on any Vancouver Scar Scale (VSS) domain.
- At 6–8 months, silicone gel produced significantly better pigmentation, height, and pliability scores than placebo/no treatment; vascularity improvement was borderline (P = .05).
- Topical silicone gel and silicone gel sheet performed comparably across all VSS domains — the dressing format itself did not change efficacy.
- Against other non-silicone topical treatments (onion extract, methylprednisolone cream), silicone gel showed no overall advantage, though it did outperform onion extract specifically in post-burn treatment (not prevention) settings.
VSS Outcomes at 6–8 Months (Silicone Gel vs. Placebo/No Treatment)
| VSS Domain | SMD (95% CI) | P value | Result |
|---|---|---|---|
| Pigmentation | −0.55 (−0.83 to −0.26) | P = .0002 | Favours gel |
| Height | −0.73 (−1.02 to −0.44) | P < .00001 | Favours gel |
| Pliability | −0.49 (−0.95 to −0.03) | P = .04 | Favours gel |
| Vascularity | −0.45 (−0.92 to 0.01) | P = .05 | No significant difference |
SMD = standardized mean difference; negative values favour the silicone gel group. Fixed-effect model applied due to low heterogeneity across studies.
Summary of All Head-to-Head Comparisons
| Comparison | Finding | Studies (n patients) |
|---|---|---|
| Silicone gel vs placebo/no treatment, 3 months | No significant difference on any VSS domain | 4 RCTs (259 patients) |
| Silicone gel vs placebo/no treatment, 6–8 months | Significantly better pigmentation, height, pliability | 3 RCTs (subset, 6–8 mo follow-up) |
| Silicone gel vs silicone gel sheet | Comparable efficacy on all VSS domains | 2 RCTs (50 patients) |
| Silicone gel vs non-silicone topicals (overall) | No significant difference | 3 RCTs (132 patients) |
| Silicone gel vs onion extract, treatment setting | Gel significantly better (post-burn scars) | Subgroup analysis |
| Silicone gel vs onion extract, prevention setting | No significant difference | Subgroup analysis |
Why This Matters for Practice
The clearest practical message from this meta-analysis is about timing: topical silicone gel's benefit did not reach statistical significance until the 6-to-8-month mark, not at 3 months. The authors explicitly recommend at least 2 months of continuous application and a follow-up period longer than 6 months to properly judge whether the treatment is working — a shorter trial period may wrongly suggest silicone gel isn't helping when in fact more time was needed.
The second practical takeaway concerns dressing choice. Since gel and sheet performed comparably in this analysis, the decision between them can reasonably be driven by patient compliance and convenience rather than efficacy alone — prior studies cited in this paper found sheets significantly more inconvenient for patients than gel, which matters for long-term adherence over a 6+ month course.
Limitations
- Only 6 studies met inclusion criteria, all with sample sizes under 100 patients — raising the possibility of small-study effect bias.
- Several eligible RCTs reported results only in graphical form and could not be included in the pooled quantitative analysis.
- Significant heterogeneity was present in several comparisons, partly attributable to inconsistent scar-measurement tools and the subjective nature of the VSS itself.
- Most included trials were not double-blind, and study quality assessment found several domains with unclear or high risk of bias.
Takeaway
This meta-analysis supports topical silicone gel as an effective option for post-operative scar prevention — but only when judged over a long enough timeframe. Benefits for pigmentation, height, and pliability emerge by 6–8 months, not 3 months, and gel performs on par with silicone gel sheet, making patient comfort and adherence a reasonable basis for choosing between the two formats. Larger, higher-quality, double-blind trials with standardized outcome measures are still needed to strengthen this evidence base.
Reference
Wang F, Li X, Wang X, Jiang X. Efficacy of Topical Silicone Gel in Scar Management: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Int Wound J. 2020;17:765–773. https://doi.org/10.1111/iwj.13337
Topical Silicone Gel in Scar Prevention — Clinical Evidence Summary
Comments 0 comment
Sign in to join the conversation.